ECL

Ecolab Inc

Add to Watchlist

Advanced Chart

271.750

+1.92(0.712%)1D

Overview
Forecast
Valuation
Earnings

High

272.320

Open

270.220

VWAP

271.43

Vol

972.47K

Mkt Cap

77.04B

Low

268.952

Amount

263.96M

EV/EBITDA(TTM)

23.22

Total Shares

285.57M

83.52B

EV/OCF(TTM)

32.96

P/S(TTM)

4.96

Ecolab Inc. is engaged in offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. The Company’s Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions primarily to large industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries. Its Global Pest Elimination segment provides services designed to detect, prevent, and eliminate pests, such as rodents and insects.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

4.03B

+1.16%

1.894

+12.76%

4.13B

+3.17%

2.065

+12.83%

4.19B

+4.57%

2.042

+12.81%

Estimates Revision

The market is revising Upward the revenue expectations for Ecolab Inc. (ECL) for FY2025, with the revenue forecasts being adjusted by 0.44% over the past three months. During the same period, the stock price has changed by 13.69%.

Revenue Estimates for FY2025

Revise Upward

+0.44%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.42%

In Past 3 Month

Stock Price

Go Up

+13.69%

In Past 3 Month

19 Analyst Rating

4.44% Upside

Wall Street analysts forecast ECL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECL is 283.81 USD with a low forecast of 243.00 USD and a high forecast of 325.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

13 Buy

6 Hold

0 Sell

Moderate Buy

4.44% Upside

Current: 271.750

Low

243.00

Averages

283.81

High

325.00

4.44% Upside

Current: 271.750

Low

243.00

Averages

283.81

High

325.00

Mizuho

Outperform

maintain

$285 -> $305

2025-07-15

Reason

Mizuho

Price Target

$285 -> $305

2025-07-15

maintain

Outperform

Reason

Mizuho raised the firm's price target on Ecolab to $305 from $285 and keeps an Outperform rating on the shares. The firm updated price targets in chemicals and packaging ahead of the Q2 reports. It says the new targets reflect the recent market multiple recovery. Mizuho's top picks are all specialty and defensive names: Corteva (CTVA), Crown (CCK) and Linde (LIN). A pause in tariffs likely pulled forward some demand, which could create a year-end slowdown, the analyst tells investors in a research note.

UBS

Neutral

maintain

$271 -> $288

2025-07-09

Reason

UBS

Price Target

$271 -> $288

2025-07-09

maintain

Neutral

Reason

UBS raised the firm's price target on Ecolab to $288 from $271 and keeps a Neutral rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.

Citi

Buy

upgrade

$285 -> $320

2025-07-03

Reason

Citi

Price Target

$285 -> $320

2025-07-03

upgrade

Buy

Reason

Citi raised the firm's price target on Ecolab to $320 from $285 and keeps a Buy rating on the shares. Driven by strong underlying growth in the Institutional and Life Sciences segments, the firm sees Ecolab "comfortably" hitting its Q2 EPS guidance midpoint of $1.89, the analyst tells investors in a preview for the firm's North America specialty chemicals coverage.

Wells Fargo

Jason Haas

Equal Weight

maintain

$250 -> $260

2025-05-20

Reason

Wells Fargo

Jason Haas

Price Target

$250 -> $260

2025-05-20

maintain

Equal Weight

Reason

Wells Fargo analyst Jason Haas raised the firm's price target on Ecolab to $260 from $250 and keeps an Equal Weight rating on the shares. The firm attended the National Restaurant Association Show in Chicago where it had the opportunity to meet with COO Darrell Brown and CFO Scott Kirkland. Management remains confident in Ecolab's ability to price its way through soft end-markets.

Seaport Global

Michael Harrison

Hold

Strong Buy

Upgrades

$290

2025-04-21

Reason

Seaport Global

Michael Harrison

Price Target

$290

2025-04-21

Upgrades

Hold

Strong Buy

Reason

Seaport Research upgraded Ecolab to Buy from Neutral with a $290 price target.

Barclays

Manav Patnaik

Buy

Maintains

$300 → $275

2025-04-17

Reason

Barclays

Manav Patnaik

Price Target

$300 → $275

2025-04-17

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Ecolab Inc (ECL.N) is 35.00, compared to its 5-year average forward P/E of 35.75. For a more detailed relative valuation and DCF analysis to assess Ecolab Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

35.75

Current PE

35.00

Overvalued PE

41.00

Undervalued PE

30.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

20.62

Current EV/EBITDA

21.46

Overvalued EV/EBITDA

23.12

Undervalued EV/EBITDA

18.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

3.99

Current PS

4.73

Overvalued PS

4.72

Undervalued PS

3.26